Fact check · Version 1 · Sources checked

“Cardiovascular trial results prove a universal longevity benefit.”

The Peptide Field explains research. Its pages are not independently medically reviewed, and they do not diagnose, prescribe, or recommend treatment.

Not established

The reviewed evidence does not establish this statement. This does not prove it can never be true.

LEADER tested a defined cardiovascular composite in a high-risk type 2 diabetes population, not lifespan extension in the general population.

What this answer is based on
This answer uses a study that assigned people to groups by chance and measured a health outcome.
Limits of this answer
Adults with type 2 diabetes and high cardiovascular risk in LEADER. These limits show which substance, product, people, use, place, and time the answer covers. A different product or situation can have a different answer.
Topic
What research does or does not show about living longer or staying healthy longer.

Sources for this fact check

Show 1 sources
Sources checked by
Site editor · Editorial review

More about Liraglutide

See the FDA and sports-rule status of Liraglutide

Other fact checks on Liraglutide